Markets
Hims oral semaglutide
A screenshot from forhers.com showing oral semaglutide (Sherwood News)

Hims reports Q4 earnings beat, revenue miss

The report comes as the company has faced mounting legal troubles related to its short-lived Wegovy pill copy.

Hims & Hers reported mixed financial results and gave a lukewarm full year guidance, moves that come after a tumultuous stretch for the telehealth company. 

For the last three months of 2025, Hims & Hers reported:

  • $0.08 earnings per share, compared to $0.04 analysts polled by FactSet were expecting.

  • $617.8 million revenue, compared to $619 million analysts were penciling in.

For the full-year 2026, the company expects:

  • Revenue to hit between $2.7 billion and $2.9 billion, compared to $2.74 billion analysts are currently expecting.

  • Adjusted EBITDA between $300 million and $375 million, compared to $369 million the Street is expecting.

The earnings report comes as the company faced massive blowback from regulators after it rolled out a copy of Novo Nordisk’s Wegovy pill early this month. Hims is now facing a patent infringement lawsuit from Novo as well as potential charges by the Department of Justice. The company said its outlook assumes that it will continue to be able to sell copycat versions of Novo's drugs.

The stock has also taken a hit: it is down more than 50% since the start of the year, with more than 30% of that drawdown coming after Hims announced the Wegovy pill copies. The stock fell about 2% in after-hours trading following the report.

As its weight loss segment sits in a precarious place, the company has focused on expanding into new treatments and geographies.

While the company does not break out revenue by treatment segment, it did say that more than half of its revenue in 2025 came from "non-GLP-1 offerings." It has added hormone treatments and labs, including a cancer detection test from Grail. Hims announced last week that it would acquire Eucalyptus, an Australian digital health company, in a deal valued up to $1.15 billion.

Last year, Hims bought Zava, a UK-based peer with a presence in France, Ireland, and Germany, for $265.7 million. It also announced that it would launch in Canada this year offering generic Wegovy. The Eucalyptus acquisition puts Hims in new markets — like Australia and Japan — and gives it a wider presence in other international markets like the United Kingdom, Germany, and Australia. 

The company also broke out its international revenue for the first time: In 2025 if it brought in $133.9 million from outside the US, compared to $26.8 million in 2024.

More Markets

See all Markets
markets

IBM sinks as Anthropic positions Claude Code as the ideal tool for code modernization

IBM is sinking as Anthropic touts Claude Code’s ability to modernize COBOL code bases.

COBOL, or Common Business-Oriented Language, is a programming language for business functions. Code written in this language has been developed and altered over decades, getting increasingly clunky and cluttered on mainframes, and the number of experts who know this language well is dwindling.

Anthropic said in a blog post that Claude Code can automate COBOL modernization, and, with the help of human judgment, migrate this code incrementally into modern languages, where it can be hosted across various cloud providers.

That is a potential threat to the likes of IBM, an architect of the COBOL system that uses the language on its mainframes for enterprises. IBM is also offering AI tools (like watsonx) to modernize COBOL code, but crucially, wants to keep the outputs running on its hardware and software.

“The strength of our Z placement fuels our flywheel for growth with its attractive 3x to 4x stack multiplier across IBM,” CFO James Kavanaugh said after the company’s latest earnings report. “Z” refers to IBM’s mainframe offerings. As such, getting and keeping customers on IBM’s mainframe is a key way the company drives revenue growth for other software and services.

COBOL is standard in many financial operations (like ATMs), as well as in government and airline systems, as Anthropic notes, so users may want to keep this code tied to one mainframe architecture for security, reliability, and speed (it’s the devil they know!) rather than migrating to a different platform.

1M 🔋🔁

Chinese EV maker Nio is climbing on Monday following news that the company provided a million battery swaps in China in less than a week. Nio shares are up about 6%.

Nio’s battery swap process is an alternative to charging. Depleted EV batteries are swapped out at stations for fully charged ones in less than three minutes — significantly faster than fast charging.

The company, which operates 3,750 swap stations, said it has broken daily swap records in China six times this month, as millions travel across the country over the Lunar New Year holiday. On Sunday, Nio performed 177,627 swaps.

Earlier this month, Nio CEO William Li said the company would add 1,000 swap stations this year.

markets

PayPal jumps after report of unsolicited takeover interest

Bloomberg reports that PayPal is the subject of takeover interest, with shares down nearly 90% from their 2021 closing high.

Per the report, management “has fielded meetings with banks amid unsolicited interest from suitors,” citing people familiar with the matter.

After being briefly halted for volatility, shares jumped 8%.

There’s reportedly appetite from “one large rival” to buy the entire company, while other potential purchasers want only certain parts.

Shares of the payments company recently closed at their lowest level since 2016, having lost ground to the likes of Apple and Google in the digital realm.

Earlier this month, shares cratered after the company posted weaker-than-anticipated Q4 results and 2026 profit guidance while announcing its CEO would soon be leaving the company.

markets

Sandisk shakes off slide from secondary offering

Sandisk continued to shake off a slump that hit the shares last week after it priced a secondary offering of almost 6 million shares owned by its former parent, Western Digital.

Tomorrow marks a year since Sandisk started trading on its own, after its spin-off from WDC. The stock soared amid a global shortage of memory chips that seemed to catch even experts completely off guard. The stock is up almost 1,300% since it began trading independently.

The company appeared to tease an event or product launch for tomorrow, February 24, in an X post on Friday, but the specifics were not entirely clear.

Sandisk’s gain over that period is the largest of any constituent of the S&P Total Market Index with a market cap of $4 billion or more — and the third-largest increase overall, out of its roughly 3,800 constituents.

Year to date, Sandisk is among the best performers in the Russell 1000 Technology Index and a key driver of the trend that has seen small clutch of hardware manufacturers trounce software shares.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.